These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 28743354)
21. The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis. Liu X; Jia R; Zhao J; Li Z J Rheumatol; 2009 Jun; 36(6):1136-42. PubMed ID: 19447936 [TBL] [Abstract][Full Text] [Related]
22. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis. Greiner A; Plischke H; Kellner H; Gruber R Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545 [TBL] [Abstract][Full Text] [Related]
23. High titers of both rheumatoid factor and anti-CCP antibodies at baseline in patients with rheumatoid arthritis are associated with increased circulating baseline TNF level, low drug levels, and reduced clinical responses: a post hoc analysis of the RISING study. Takeuchi T; Miyasaka N; Inui T; Yano T; Yoshinari T; Abe T; Koike T Arthritis Res Ther; 2017 Sep; 19(1):194. PubMed ID: 28865493 [TBL] [Abstract][Full Text] [Related]
24. Comparison of anti-mutated citrullinated vimentin, anti-cyclic citrullinated peptides, anti-glucose-6-phosphate isomerase and anti-keratin antibodies and rheumatoid factor in the diagnosis of rheumatoid arthritis in Chinese patients. Zhu T; Feng L Int J Rheum Dis; 2013 Apr; 16(2):157-61. PubMed ID: 23773638 [TBL] [Abstract][Full Text] [Related]
25. HLA-DRB1 shared epitope alleles in patients with rheumatoid arthritis: relation to autoantibodies and disease severity in a south Indian population. Konda Mohan V; Ganesan N; Gopalakrishnan R; Venkatesan V Int J Rheum Dis; 2017 Oct; 20(10):1492-1498. PubMed ID: 27943654 [TBL] [Abstract][Full Text] [Related]
26. [Antibodies to mutated citrullinated vimentin and some associated autoantibodies in juvenile idiopathic arthritis]. Zhang L; Ru J; Jie X; Che G; Jin X; Li X Zhonghua Er Ke Za Zhi; 2015 Dec; 53(12):948-51. PubMed ID: 26887552 [TBL] [Abstract][Full Text] [Related]
27. Association of rheumatoid arthritis-related autoantibodies with pulmonary function test abnormalities in a rheumatoid arthritis registry. Huang S; He X; Doyle TJ; Zaccardelli A; Marshall AA; Friedlander HM; Blaustein RB; Smith EA; Cui J; Iannaccone CK; Mahmoud TG; Weinblatt ME; Dellaripa PF; Shadick NA; Sparks JA Clin Rheumatol; 2019 Dec; 38(12):3401-3412. PubMed ID: 31410660 [TBL] [Abstract][Full Text] [Related]
28. Arthritis autoantibodies in individuals without rheumatoid arthritis: follow-up data from a Dutch population-based cohort (Lifelines). Westra J; Brouwer E; Raveling-Eelsing E; Arends S; Eman Abdulle A; Roozendaal C; van Delft MAM; Toes REM; Trouw LA; Vissink A; de Smit MJ Rheumatology (Oxford); 2021 Feb; 60(2):658-666. PubMed ID: 32594174 [TBL] [Abstract][Full Text] [Related]
29. Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: an Italian multicentric study and review of the literature. Bartoloni E; Alunno A; Bistoni O; Bizzaro N; Migliorini P; Morozzi G; Doria A; Mathieu A; Lotzniker M; Allegri F; Riccieri V; Alpini C; Gabrielli A; Tampoia M; Gerli R; Autoimmun Rev; 2012 Sep; 11(11):815-20. PubMed ID: 22394488 [TBL] [Abstract][Full Text] [Related]
30. Frequency of serological markers of rheumatoid arthritis in patients with Hashimoto's thyroiditis. Ghozzi M; Mankai A; Melayah S; Mechi F; Chedly Z; Trabelsi A; Ghedira I Lab Med; 2024 Jul; 55(4):433-438. PubMed ID: 38035768 [TBL] [Abstract][Full Text] [Related]
31. Autoantibodies in prediction of the development of rheumatoid arthritis among healthy relatives of patients with the disease. Ramos-Remus C; Castillo-Ortiz JD; Aguilar-Lozano L; Padilla-Ibarra J; Sandoval-Castro C; Vargas-Serafin CO; de la Mora-Molina H; Ramos-Gomez A; Sanchez-Ortiz A; Avila-Armengol H; Aceves-Avila FJ Arthritis Rheumatol; 2015 Nov; 67(11):2837-44. PubMed ID: 26245885 [TBL] [Abstract][Full Text] [Related]
32. Diagnostic performance of anti-cyclic citrullinated peptide and rheumatoid factor in patients with rheumatoid arthritis. Chang PY; Yang CT; Cheng CH; Yu KH Int J Rheum Dis; 2016 Sep; 19(9):880-6. PubMed ID: 25940989 [TBL] [Abstract][Full Text] [Related]
33. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features. Reyes-Castillo Z; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla GE; del Toro-Arreola S; Ramírez-Dueñas MG; Ocampo-Bermudes G; Muñoz-Valle JF Clin Exp Immunol; 2015 Nov; 182(2):119-31. PubMed ID: 26149185 [TBL] [Abstract][Full Text] [Related]
34. Anti-MCV antibodies predict radiographic progression in Greek patients with very early (<3 months duration) rheumatoid arthritis. Barouta G; Katsiari CG; Alexiou I; Liaskos C; Varna A; Bogdanos DP; Germenis AE; Sakkas LI Clin Rheumatol; 2017 Apr; 36(4):885-894. PubMed ID: 27943044 [TBL] [Abstract][Full Text] [Related]
35. Overlap between systemic sclerosis and rheumatoid arthritis: a distinct clinical entity? Horimoto AM; da Costa IP Rev Bras Reumatol Engl Ed; 2016; 56(4):287-98. PubMed ID: 27476621 [TBL] [Abstract][Full Text] [Related]
36. Carbamylated vimentin represents a relevant autoantigen in Latin American (Cuban) rheumatoid arthritis patients. Martínez G; Gómez JA; Bang H; Martínez-Gamboa L; Roggenbuck D; Burmester GR; Torres B; Prada D; Feist E Rheumatol Int; 2016 Jun; 36(6):781-91. PubMed ID: 27038800 [TBL] [Abstract][Full Text] [Related]
37. An exploratory study to determine whether infliximab modifies levels of rheumatoid factor and antibodies to cyclic citrullinated peptides in rheumatoid arthritis patients. Martínez-Estupiñán L; Hernández-Flórez D; Janta I; Ovalles-Bonilla JG; Nieto JC; González-Fernández CM; Del Río T; Monteagudo I; López-Longo FJ; Naredo E; Valor L Clin Exp Rheumatol; 2018; 36(1):88-93. PubMed ID: 28850020 [TBL] [Abstract][Full Text] [Related]
38. Antibodies binding to citrullinated telopeptides of type I and type II collagens and to mutated citrullinated vimentin synergistically predict the development of seropositive rheumatoid arthritis. Koivula MK; Heliövaara M; Rissanen H; Palosuo T; Knekt P; Immonen H; Risteli J Ann Rheum Dis; 2012 Oct; 71(10):1666-70. PubMed ID: 22419777 [TBL] [Abstract][Full Text] [Related]
39. The Potent Inhibitory Effect of β-D-Mannuronic Acid (M2000) as a Novel NSAID with Immunosuppressive Property on Anti-Cyclic Citrullinated Peptide Antibodies, Rheumatoid Factor and Anti-dsDNA Antibodies in Patients with Rheumatoid Arthritis. Ahmadi H; Jamshidi AR; Mahmoudi M; Cuzzocrea S; Fattahi MJ; Barati A; Rehm BHA; Matsuo H; Mirshafiey A Curr Drug Discov Technol; 2017; 14(3):206-214. PubMed ID: 28325148 [TBL] [Abstract][Full Text] [Related]
40. Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides. Mathsson L; Mullazehi M; Wick MC; Sjöberg O; van Vollenhoven R; Klareskog L; Rönnelid J Arthritis Rheum; 2008 Jan; 58(1):36-45. PubMed ID: 18163519 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]